wire - news in brief


Category



Results 251 - 300 of 416.


Pedagogy - 10.06.2021
'Mars Mission' attracts more than 700 students from around the world
’Mars Mission’ attracts more than 700 students from around the world
The R2T2 Mars Mission is an educational project developed at EPFL for grade-school and high-school classes that use the Thymio robot.

Computer Science - Campus - 10.06.2021

Innovation - Environment - 10.06.2021
NEST to open its virtual doors
The research and innovation building NEST of Empa and Eawag can now be visited virtually at any time and from anywhere in the world.

Research Management - Campus - 09.06.2021

Veterinary - 08.06.2021
No room for discrimination or harassment
Discrimination and harassment violate scientific integrity - but the damage they do goes beyond that.

Physics - Chemistry - 08.06.2021

Pharmacology - Health - 07.06.2021
Novartis announces new interim analysis Phase II data for iptacopan in rare kidney disease C3 glomerulopathy (C3G)
Data shows investigational iptacopan improved estimated glomerular filtration rate (eGFR) slope and stabilized kidney function in patients with C3G 1 ; Phase III clinical trial to start in 2021 Resul

Health - Life Sciences - 07.06.2021
Modelling lungs to limit testing on mice
Modelling lungs to limit testing on mice
The UNIGE is awarding its 3R prize to the creator of a cell model which, by reproducing a lung infection, has enabled the identification of a promising treatment.  Pseudomonas aeruginosa is a bacterium responsible for many lung infections, particularly in people with cystic fibrosis or a weakened immune system.

Environment - Architecture - 07.06.2021
EPFL architecture students explore outdoor spaces in Geneva Canton
EPFL architecture students explore outdoor spaces in Geneva Canton
Throughout the summer, architectural works by first-year students at EPFL's ALICE studio will be on display at four sites in Geneva Canton: Genthod, Aigues-Vertes, Vernier and Onex.

Pharmacology - Health - 07.06.2021
Approval for New Alzheimer’s Drug Developed at UZH
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer's disease.

Pharmacology - Health - 06.06.2021
Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)
Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduc tion of proteinuria 1 - a key risk predictor in kidney disease progressi

Pharmacology - Health - 04.06.2021
Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma
Data for investigational CD20xCD3 bispecific antibodies and new combination regimens with Polivy showed enhanced clinical benefits for people with non-Hodgkin lymphoma in early studies Basel, 4 June

Health - Environment - 04.06.2021
Researchers put technology to work for the global South
Researchers put technology to work for the global South
Tech4Dev, an EPFL program to develop technology that addresses the specific needs and living conditions of communities in the developing world, has announced four new winning projects for its research grants.

Environment - Social Sciences - 04.06.2021
A social network for global ecosystem restoration
A social network for global ecosystem restoration
ETH spin-off Restor aims to increase the success rate of ecosystem restoration and conservation projects by connecting people with better data and ecological transparency.

Pharmacology - Health - 04.06.2021
Novartis announces Tabrecta first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC
Tabrecta (capmatinib) showed a median overall survival (OS) of 20.8 months in treatment-naïve patients and 13.6 months in previously-treated patients in first published mature data 1,2

Economics / Business - Health - 04.06.2021

Astronomy / Space Science - 03.06.2021
Attractive locations work like large planets
Attractive locations work like large planets
Using large-scale mobility data from diverse cities around the globe, researchers from ETH Zurich, MIT and the Santa Fe Institute discover a powerful yet surprisingly simple travel law that governs the number of visitors to any location in a city.

Health - Life Sciences - 03.06.2021
Better choice of contraceptives can prevent breast cancer
Better choice of contraceptives can prevent breast cancer
There is a strong link between hormonal contraceptives and breast cancer risk. The main culprit are progestins, synthetic mimics of the pregnancy hormone progesterone that stimulate cell growth in the breast.

Materials Science - Environment - 03.06.2021
The biodegradable battery
The biodegradable battery
The number of data-transmitting microdevices, for instance in packaging and transport logistics, will increase sharply in the coming years.

Pharmacology - Health - 03.06.2021
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
At final analysis, study showed clinically relevant improvement in median overall survival with a difference of 11.7 months between arms (Hazard ratio (HR): 0.84 with 95% CI: (0.

Economics / Business - 02.06.2021
Implications of 'short squeezes' on financial market efficiency
Implications of ’short squeezes’ on financial market efficiency
Financial markets are often subject to sudden asset price surges and dips, most of the time due to the classic market dynamics of mismatched supply and demand.

Pharmacology - Health - 02.06.2021
Novartis Kisqali reports longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients
MONALEESA-3 median overall survival (OS) results of 53.7 months underscore that Kisqali offers more life to postmenopausal women with HR+/HER2- metastatic breast cancer (MBC) in addition to th

Health - Pharmacology - 01.06.2021
The simulated patient
The simulated patient
Digital twins enable customized medical therapies. researchers have now modeled several hundred such avatars based on real people and treated them experimentally.

Pharmacology - Health - 01.06.2021
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
Approval for moderate to severe pediatric patients six years and older is based on pivotal trial data showing Cosentyx demonstrated superior improvements of skin symptoms compared to placebo 1 The sa

Environment - Economics / Business - 31.05.2021
Climate protection provides cheaper energy
Climate protection provides cheaper energy
Although measures taken to mitigate the effects of climate change are generally associated with energy levies and high costs, the opposite is actually true: the switch to renewable sources is set to reduce energy prices significantly.

Economics / Business - 31.05.2021

Health - Environment - 31.05.2021
Global warming already responsible for one in three heat-related deaths
Global warming already responsible for one in three heat-related deaths
An international study coordinated by the University of Bern and the London School of Hygiene & Tropical Medicine shows for the first time the actual contribution of man-made climate change in increa

Environment - Earth Sciences - 28.05.2021
Untapped solar and wind potential in Swiss mountains
Untapped solar and wind potential in Swiss mountains
Scientists at EPFL and the WSL Institute for Snow and Avalanche Research SLF have issued recommendations for what type of renewable energy should be produced in Switzerland's various regions, to help achieve the country's goals of carbon neutrality and energy self-sufficiency. According to a new study, the most effective way for Switzerland to become carbon-neutral and energy self-sufficient is to install a combination of wind turbines and solar panels in its Alpine regions.

Architecture - Computer Science - 27.05.2021

Transport - 27.05.2021
Which type of transportation user are you?
Which type of transportation user are you?
Sociologists at EPFL conducted a survey of the factors that prompt people to select one form of transportation over another, and then compared the results from cities across Switzerland.

Economics / Business - Environment - 26.05.2021
Missing Role of Finance in Climate Mitigation Scenarios
Missing Role of Finance in Climate Mitigation Scenarios
Researchers at the University of Zurich show how climate mitigation scenarios can be improved by taking into account that the financial system can play both an enabling or a hampering role on the path to a sustainable economic system. To limit global warming, a profound transformation of energy, production and consumption in our economies is required.

Life Sciences - Psychology - 26.05.2021
'Tug of war' between neurons tells the brain when to fear — and when not to be afraid
’Tug of war’ between neurons tells the brain when to fear — and when not to be afraid
Fear protects us by making us alert to danger, but the persistence of fearful memories can lead to serious mental conditions. Now, an international team of researchers co-led by Andreas Lüthi has found that the activity of different cells in the brain's threat-detector hub regulates the switch between high and low fear states.

Astronomy / Space Science - Chemistry - 21.05.2021

Campus - Physics - 21.05.2021

Environment - Life Sciences - 21.05.2021
'The change in forests' carbon role is a threat to the climate'
’The change in forests' carbon role is a threat to the climate’
The Amazon rain forest may have reached a tipping point. According to a recent study, it now emits more CO2 than it absorbs, which could speed the pace of climate change.

Health - Campus - 20.05.2021
Vice-Rector for Research Daniel Candinas resigns
Vice-Rector for Research Daniel Candinas resigns
After more than five years in the University Executive Board, Daniel Candinas will step down as Vice-Rector for Research of the University of Bern at the end of 2021.